The research presented is part of, «A Randomized Trial of Induction
Versus Expectant Management,» more commonly referred to as the ARRIVE Trial, which was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Active
versus expectant management in the third stage of labour.
Until recently, a Cochrane review on «Active
versus expectant management in the third stage of labour» suggested that administration of synthetic oxytocin (Syntocinon ® or Syntometrine ®) is preferred to expectant management — or simply allowing the placenta time to peel away from the uterine lining and to be expelled.
Not exact matches
Similarly, in another large cohort, the rate of VBAC was higher among women undergoing induction of labor at 39 weeks compared with
expectant management (73.8 %
versus 61.3 %, P <.001)(104).